Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Boya Pharmaceutical Technology Development is a specialized pharmaceutical research and development organization based in Changsha, China. Established in 2003, the company focuses on providing comprehensive R&D services for chemical drugs, including synthesis, formulation development, and quality control. It operates primarily as a Contract Research Organization (CRO) and technology transfer partner, assisting pharmaceutical enterprises with regulatory submissions and clinical trial management. The company is recognized as a high-tech enterprise in Hunan Province and plays a significant role in the regional pharmaceutical innovation ecosystem. Its expertise spans from early-stage laboratory research to pilot-scale production and technology industrialization. Changsha Boya supports the development of both generic and innovative small molecule therapeutics for the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Boya Pharmaceutical Technology Development.